ImmunologybioRxiv
Tumor MHCII immunity requires in situ antigen presentation by cancer-associated fibroblasts.
D. Kerdidani, E. Aerakis, K.-M. Verrou…·M. Tsoumakidou
This study shows that cancer-associated fibroblasts present antigens in situ to activate CD4 T cells, enhancing tumor immunity and suggesting new therapeutic strategies.